Sponsor Pipeline

T-MAXIMUM Pharmaceutical Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07386002 The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Not Yet Recruiting
Disease Areas
Glioblastoma (1)
Get alerts when T-MAXIMUM Pharmaceutical Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free